DUBLIN–(BUSINESS WIRE)–The “Topical Drug Delivery Market Research Report by Product, Rout to Administration, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The Global Topical Drug Delivery Market size was estimated at USD 101.10 billion in 2021, USD 107.74 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.75% to reach USD 149.61 billion by 2027.
In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Cumulative Impact of COVID-19:
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.
This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Topical Drug Delivery market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.
It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others.
Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The report provides insights on the following pointers:
- Market Penetration: Provides comprehensive information on the market offered by the key players
- Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
- Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
- Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
- Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
Company Usability Profiles:
- Absorption Systems LLC
- Bausch Health Companies Inc
- Bayer AG
- Cipla Limited
- Crescita Therapeutics Inc.
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- Hisamitsu Pharmaceutical Co., Inc.
- Janssen Global Services, LLC
- MedPharm Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Nestle S.A.
- Novartis International AG
- The Lubrizol Corporation
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of skin diseases
5.1.1.2. Rising prevalence of eye diseases
5.1.1.3. High incidence of burn injuries
5.1.1.4. Increasing prevalence of diabetes
5.1.2. Restraints
5.1.2.1. Preference for alternative modes of drug delivery
5.1.3. Opportunities
5.1.3.1. Delivery of biologics through the transdermal route
5.1.3.2. Self-administration and home care
5.1.4. Challenges
5.1.4.1. Technical barriers related to skin irritation and permeability
5.1.4.2. Drug failures and product recalls
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Topical Drug Delivery Market, by Product
6.1. Introduction
6.2. Liquid Formulations
6.2.1. Solutions
6.2.2. Suspensions
6.3. Semi-Solid Formulations
6.3.1. Creams
6.3.2. Gels
6.3.3. Lotions
6.3.4. Ointments
6.3.5. Pastes
6.4. Solid Formulations
6.4.1. Powders
6.4.2. Suppositories
6.5. Transdermal Products
6.5.1. Transdermal Patches
6.5.2. Transdermal Semi-Solids
7. Topical Drug Delivery Market, by Rout to Administration
7.1. Introduction
7.2. Dermal Drug Delivery
7.3. Nasal Drug Delivery
7.4. Ophthalmic Drug Delivery
7.5. Rectal Drug Delivery
7.6. Vaginal Drug Delivery
8. Topical Drug Delivery Market, by End-User
8.1. Introduction
8.2. Burn Centers
8.3. Home Care Settings
8.4. Hospitals and Clinics
9. Americas Topical Drug Delivery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Topical Drug Delivery Market
11. Europe, Middle East & Africa Topical Drug Delivery Market
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
13. Company Usability Profiles
For more information about this report visit https://www.researchandmarkets.com/r/qweqvl
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900